China Auto Parts Industry 1h11 – Overview,trends,analysis,outlook And Swot

Emerging Markets Direct released their latest China Auto Parts Industry Report 1H11 . China overtook the US as the worlds largest automotive market in 2009. The Chinese market was expected to grow by 24% to 17 million vehicles in 2010. Boosted by the overall development of the automotive industry, the auto parts industry has been experiencing rapid growth and changes in the past few years. Ever since Chinas accession into the WTO, foreign auto giants have flocked to China to secure the market share.

ASEAN, and other Asia-Pac countries together take up Chinas largest components. In the first quarter of 2010, it went up to USD1.8 billion, which constituted 30% of total exports. North America continues to hold the top ranking for brakes,tires and other mechanical parts which generated around one-forth of the aggregate sales in the first three months of 2010. While EU was the second largest market for brakes and electronic parts, just behind North America and Asia-Pac.

For the period between 2002 to 2008, auto parts manufacturers registered an annual growth of 20% per annum, while the total value output of auto parts reached RMB1.2 trillion, up 26.7% from 2008. The strong growth in the industry has attracted a pool of companies to join the arcade and has resulted in foreign companies accounting for seven out of the ten biggest component companies operating in China . The manufacturers sprout out in almost every part of the country and widely dispersed.

The government encouraged the overall growth of the automotive sector and laid out the Automotive Industry Development Policy and 11th Five-Year Plan, targeted to consolidate the auto parts companies and boost up the industry to international standard. Our analyst thinks that parts productions in China are still lagging behind the development of vehicle production, with weak R&D skills in terms of new technologies development and production systems management. Greater initiative is required to promote mergers and acquisitions, as a solution for large component groups to reach out and upgrade the product and managerial skills.

What are the challenges facing the industry? How about the outlook? Want to get hold of the policy put forward by the government? What are the trade conditions for different auto parts?

The answers are here in our latest in our latest number. Complete with full analysis (SWOT analysis) of key industry players of China Auto Parts Industry including:
– Weifu High-Technology Co., Ltd
– Weichai Power Co., Ltd
– WanXiang QianChao Co., Ltd
– FuYao Glass Group Industries Co., Ltd
– Ningbo Huaxiang Electronic Co., Ltd

Profit now from our China Auto Parts Industry Report:
http://www.emergingmarketsdirect.com/products/China-Auto-Parts-Industry.html

Table of Content
1. Industry Profile
1.1 China Economic Overview
1.2 Asia Pacific Automotive Industry Overview
1.3 China Automotive Industry Overview
1.4 China Auto Parts Industry Overview
1.5 Production
1.6 Foreign Trade
2. Market Trends and Outlook
2.1 Industry Structure
2.2 Market Trends
2.3 Policy Developments
2.4 Challenges
2.5 Outlook
3. Leading Players and Comparative Matrix
3.1 Leading Players
3.1.1 Weifu High-Technology Co., Ltd
3.1.2 Weichai Power Co., Ltd
3.1.3 WanXiang QianChao Co., Ltd
3.1.4 FuYao Glass Group Industries Co., Ltd
3.1.5 Ningbo Huaxiang Electronic Co., Ltd
3.2 Comparative Matrix
3.3 SWOT Analysis

4. Tables and Charts
Table 1: Vehicle Production by Type in China 2006-2010
Table 2: Export of Auto Components January December 2010
Table 3: Imports of Auto Components January December 2010
Table 4: WFHT Main Operations by Products
Table 5: WFHT Main Operations and Market Share
Table 6: Weichai Revenue and Cost by Product (RMB millions) 2008 and 2009
Table 7: WXQC Revenue Income and Cost 2008-2009
Table 8: Fuyao Revenue and Cost by Products
Table 9: NBHX Sales Analysis 2005-2009
Table 10: Financial Highlights of Leading Players 1H2010
Chart 1: China GDP Growth 2001-2010
Chart 2: China Consumer Price Index 2010 (January-December)
Chart 3: Production Figures for Selected Countries (units)
Chart 4: Chinas Vehicle Production (‘000 units) 2005-9M10
Chart 5: Trade of Electric Control Fuel 2004-November 2010
Chart 6: Trade of Car Bodies 2004-November2010
Chart 7: Trade of Lap Belts 2004-November2010
Chart 8: Trade of Air Bags 2004-November2010
Chart 9: Trade of Gear Boxes 2004-November2010
Chart 10: Trade of Clutches 2004-November2010
Chart 11: Trade of Dampers2004-November2010
Chart 12: Key Automotive Producing Locations in China
Chart 13: China’s Leading Auto Part Makers
Chart 14: WFHT Historic PE Band
Chart 15: WFHT Historic PB Band
Chart 16: Weichai Historic Basic EPS 2005-1H10
Chart 17: Automobile Glass Production Cost Structure

China Pharmaceutical Industry – Overview,trends,analysis,outlook And Swot

Emerging Markets Direct (EMD) announced the release of their latest China Pharmaceutical Industry Report1H11. China Pharmaceutical market has been growing rapidly as the fourth-largest market in the world in terms of size. As one of the pharmerging markets in BRIC, the industry is expected to grow at 12.5% CAGR during 2009 2014. Backed by vast pool of talent, low-cost manufacturing capabilities, and huge market potential, it has attracted several global drug giants to outsource their R&D and invest in China.

While the market size of China Pharmaceuticals in 2009 was USD46.15billion, its overall health expenditure was among the lowest in the world comparable to that of Morocco, India or Saudi Arabia. In 2009, Chinas overall health expenditure was at USD230.7 billion, a 4.7% of total GDP. The industry is well-known for its fragmented nature with 7,664 enterprises in 2009, out of which local domestic enterprises account for 70% of industry sales.

Government policies change the landscape of pharmaceutical industry in China. A three-year health care reform was introduced in 2009 attempting to increase medical insurance coverage, upgrade grassroots medical institution and set up the basic medicine system. These gave a push to the generic pharmaceuticals with measures taken to curb over-prescription of unnecessary drugs. As a matter of fact, high-end drug distributors would be encouraged to consolidate in order to stay competitive.

Over-the-counter pharmaceuticals market is a growing segment in the Chinese pharmaceutical industry and set to double its market share by 2014. Backed by the aging population, increasing disposable income levels, and growth in the awareness of health care. Our analysts expect Over-the-counter purchases to increase along with the growth in the pharmaceutical industry as a whole. Facing the tough competition from hospitals, the market is set to diversify with vitamins, minerals and supplements leading the growth of this segment.
Generic Drugs market will boom for the next 4 years to come as expiring blockbuster drug patents cause a surge in generic drug production. Whats more, Generic segment remains attractive to foreign investments, where multinational companies merge and acquire generic drug companies to compensate for the loss of income from expiring patents. Our analysts think that generic segment will capture a larger consumer base owing to the health-care subsidy put forward by Chinese government.

What are the prevailing problems in the pharmaceutical industry? How is the development of Traditional Chinese Medicine market? What are the competitive advantages of China pharmaceutical research? How does the condition of patent law and intellectual property rights affect the industry? What are the trends and outlook of the China pharmaceutical industry? Which are the top 100 Chinese Pharmaceutical Enterprises in 2009? How about the SWOT analysis of China Pharmaceutical market?

The answers are here in our latest in our latest number. Complete with full analysis of key players including:
-Harbin Pharmaceutical Group Co.Ltd.
-Northeast Pharmaceutical Co.Ltd.
-North China Pharmaceutical Co. Ltd.
-Beijing Double-Crane Pharmaceutical Co.Ltd.

Profit now from our China Pharmaceutical Industry Report1H11

Table of Content
1. Industry Profile
1.1 Industry Overview
1.1.1 Structure of Chinas Pharmaceutical Industry
1.1.2 Industry Size And Value
1.2 Industry Production
1.3 Government Policies
1.3.1 Healthcare Reform Policy
1.3.2 11th Five-Year Plan
1.3.3 Intellectual Property Rights (IPR)
1.3.4 Administrative Protection
1.4 Pharmaceutical Industry Issues
1.5 Global Pharmaceutical Industry Trends
2. Market Trends and Outlook
2.1 Traditional Chinese Medicine (TCM) Market
2.2 Over-The-Counter (OTC) Pharmaceuticals Market
2.3 Generic Drugs Market
2.4 Research and Development (R&D)
2.4.1 Competitive Advantages In China Pharmaceutical Research
2.5 Imports and Exports
2.6 Merger & Acquisitions (M&A) of Companies
2.7 Market Outlook
3. Leading Players and Comparative Matrix
3.1 Leading Players
3.1.1 Harbin Pharmaceutical Group Co., Ltd.
3.1.2 Northeast Pharmaceutical Co., Ltd. (NPC)
3.1.3 North China Pharmaceutical Co., Ltd. (NCP)
3.1.4 Beijing Double-Crane Pharmaceutical Co., Ltd. (BDCP)
3.2 Comparative Matrix
3.3 Top 100 Pharmaceutical Enterprises in China
3.4 SWOT Analysis of the Pharmaceutical Market In China

4. Tables & Charts
Table 1: Summary of Chinese Pharmaceutical Market in 2009
Table 2: List of major drug patent expiry from 2010 to 2011
Table 3: Harbin Pharmaceutical Group Co., Ltd.: Financial Highlights 2007-2009
Table 4: Northeast Pharmaceutical Co., Ltd.: Financial Highlights 2007-2009
Table 5: North China Pharmaceutical Co., Ltd.: Financial Highlights 2007-2009
Table 6: Beijing Double-Crane Pharmaceutical Co., Ltd.: Financial Highlights 2007-2009
Table 7: Financial Highlights of the Leading Players 2008-2009
Table 8: Top 100 Chinese Pharmaceutical Enterprises in 2009
Chart 1: Gross Industrial Output of Medical and Pharmaceutical Products 2006-2009
Chart 2: No of Pharmaceutical Enterprises In China 2005-2009
Chart 3: 2009-2011Healthcare Reform
Chart 4: Global Pharmaceutical Market Size 2005-2009
Chart 5: OTC Pharmaceuticals Market Value 2005-2009
Chart 6: Total OTC Sales in 2009 by Breakdown
Chart 7: Import and Exports of Pharmaceuticals 2006-2009
Chart 8: China Pharmaceutical Market Projections (excl. HK) 2009-2014(f)